Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations
Satoshi Inoue(Institute for Advanced Medical Research), Hiroyuki Mano(National Cancer Research Institute), Yasuhisa Terao(Juntendo University), Tsuyoshi Saito(Sapporo Medical University), Yasushi Hirota(The University of Tokyo), Reina Takeyama, Yosuke Tanaka, Masahito Kawazu(Chiba Cancer Center), Yutaka Osuga(The University of Tokyo), Ayumi Taguchi(Daiichi-Sankyo (Japan)), Kengo Takeuchi(Japanese Foundation For Cancer Research), Takuo Hayashi(Juntendo University), Satoko Osuka(Nagoya University), Masako Ikemura(The University of Tokyo), Emiko Yoshida(Juntendo University), Seiji Sakata(Japanese Foundation For Cancer Research), Ayako Muraoka(Nagoya University), Toshihide Ueno, Taiki Hashimoto(Tokyo National Hospital), Tomoki Tanaka(Tokyo Metropolitan Institute of Gerontology), Shinya Kojima, Katsutoshi Oda(The University of Tokyo), Yamato Fukui(The University of Tokyo), Tohru Kiyono
Cited by 137
Related Papers
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
|Cancer Cell|2022|828
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
|Nature Immunology|2020|810
Oral Frailty as a Risk Factor for Physical Frailty and Mortality in Community-Dwelling Elderly
|The Journals of Gerontology Series A|2017|800
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
|Nature Genetics|2010|725
Development of a simple screening test for sarcopenia in older adults
|Geriatrics and gerontology international/Geriatrics & gerontology international|2014|386